Skip to main content
Advertisement
Advertisement

BSX

BSX logo

Boston Scientific Corp.

44.38
USD
Sponsored
+0.52
+1.17%
Sep 16, 12:02 UTC -4
Open

BSX Earnings Reports

Positive Surprise Ratio

BSX beat 34 of 42 last estimates.

81%

Next Report

Date of Next Report
Oct 28, 2026
Estimate for Q3 26 (Revenue/ EPS)
$5.25B
/
$0.79
Implied change from Q2 26 (Revenue/ EPS)
-3.44%
/
-8.14%
Implied change from Q3 25 (Revenue/ EPS)
+3.75%
/
+5.33%

Boston Scientific Corp. earnings per share and revenue

On Jul 29, 2026, BSX reported earnings of 0.86 USD per share (EPS) for Q2 26, beating the estimate of 0.83 USD, resulting in a 2.94% surprise. Revenue reached 5.44 billion, compared to an expected 5.42 billion, with a 0.50% difference. The market reacted with a -0.04% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 21 analysts forecast an EPS of 0.79 USD, with revenue projected to reach 5.25 billion USD, implying an decrease of -8.14% EPS, and decrease of -3.44% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Kestra Medical Technologies, Ltd. Common Stock
Report Date
Sep 14, 2026 For Q1 27
Estimate
-$0.62
Actual
-$0.75
Surprise
-19.39%
logo
High Tide Inc. Common Shares
Report Date
Sep 14, 2026 For Q3 26
Estimate
$0.01
Actual
$0.02
Surprise
+175.29%
FAQ
For Q2 2026, Boston Scientific Corp. reported EPS of $0.86, beating estimates by 2.94%, and revenue of $5.44B, 0.5% above expectations.
The stock price moved down -0.04%, changed from $46.06 before the earnings release to $46.04 the day after.
The next earning report is scheduled for Oct 28, 2026.
Based on 21 analysts, Boston Scientific Corp. is expected to report EPS of $0.79 and revenue of $5.25B for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement